Co-Chair

Julie Carbray

PhD, PMHNP-BC, PMHCNS-BC, FAAN
Clinical Professor of Psychiatry and Nursing
University of Illinois Chicago

Dr. Carbray holds her PhD (93) and Master of Science (88) degrees from Rush University, Chicago and her Bachelor of Science (87) degree from Purdue University in West Lafayette, Indiana. A Clinical Professor of Psychiatry and Nursing at the University of Illinois Chicago, she has been practicing as a Psychiatric Nurse Practitioner over 35 years. As UIC faculty, Dr. Carbray teaches course content in psychopharmacology, mood disorders, and development and therapeutic interventions with children and adolescents for students across various multidisciplinary programs. As the Director of the Pediatric Mood Disorder Clinic, Dr. Carbray leads the clinical program and multidisciplinary training and is a nationally recognized clinical expert in children and adolescents with mood disorders. Dr. Carbray holds a national reputation of excellence in serving families of children with mood disorders, and was recognized with the UIC Preceptor of the year award, the Karen Gousman Excellence in Nursing Award, the American Psychiatric Nurses Association Best Practices in an Outpatient Program for Bipolar Disorder Award, the UIC Inspire Award, the APNA Distinguished Service Award and the Susan McCabe psychopharmacology lectureship from the International Society of Psychiatric Nurses. Dr Carbray has presented her work nationally and internationally and across communities and organizations including the American Girl Company. With a particular focus on helping families to help their children with mood disorders, Dr. Carbray has engaged in programs of research that are investigating the psychopharmacology of mood disorders, neurobiology of mood disorders, and neurobiologically informed treatments and family response to childhood mood disorders.

2026 Sessions

Psych Congress Orientation Session (Non-Accredited)

Speaker

Tuesday, September 15 7:00–7:30 AM
Room 211-213
Co-Chair

Julie Carbray

PhD, PMHNP-BC, PMHCNS-BC, FAAN
Clinical Professor of Psychiatry and Nursing
University of Illinois Chicago

Dr. Carbray holds her PhD (93) and Master of Science (88) degrees from Rush University, Chicago and her Bachelor of Science (87) degree from Purdue University in West Lafayette, Indiana. A Clinical Professor of Psychiatry and Nursing at the University of Illinois Chicago, she has been practicing as a Psychiatric Nurse Practitioner over 35 years. As UIC faculty, Dr. Carbray teaches course content in psychopharmacology, mood disorders, and development and therapeutic interventions with children and adolescents for students across various multidisciplinary programs. As the Director of the Pediatric Mood Disorder Clinic, Dr. Carbray leads the clinical program and multidisciplinary training and is a nationally recognized clinical expert in children and adolescents with mood disorders. Dr. Carbray holds a national reputation of excellence in serving families of children with mood disorders, and was recognized with the UIC Preceptor of the year award, the Karen Gousman Excellence in Nursing Award, the American Psychiatric Nurses Association Best Practices in an Outpatient Program for Bipolar Disorder Award, the UIC Inspire Award, the APNA Distinguished Service Award and the Susan McCabe psychopharmacology lectureship from the International Society of Psychiatric Nurses. Dr Carbray has presented her work nationally and internationally and across communities and organizations including the American Girl Company. With a particular focus on helping families to help their children with mood disorders, Dr. Carbray has engaged in programs of research that are investigating the psychopharmacology of mood disorders, neurobiology of mood disorders, and neurobiologically informed treatments and family response to childhood mood disorders.

Co-Chair

Gregory Mattingly

MD
Associate Clinical Professor, Department of Psychiatry
Washington University School of Medicine, Midwest Research Group, St. Louis, MO, United States

Dr. Mattingly is a physician and principal investigator in clinical trials for Midwest Research Group. He is also a founding partner of St. Charles Psychiatric Associates where he treats children, adolescents and adults. A St Louis native, he earned his medical degree and received a Fulbright scholarship while attending Washington University. Dr. Mattingly is board certified in adult and adolescent psychiatry and is a Diplomat of the National Board of Medical Examiners. He is an Associate Clinical Professor at Washington University where he teaches psychopharmacology courses for the 3rd year medical students. Dr. Mattingly has been a principal investigator in over 400 clinical trials focusing on ADHD, anxiety disorders, major depression, bipolar disorder and schizophrenia. Having served on numerous national and international advisory panels, Dr. Mattingly has received awards and distinctions for clinical leadership and neuroscience research. Dr Mattingly is the President for APSARD-The American Professional Society of ADHD and Related Disorders and is on the Scientific Advisory Board for the Workd Federation of ADHD. Having served on the board of Headway House, a community support program and as a certifed evaluator for both the NFL and MLB, Dr Mattingly is firm believer in holistic mental health, education and advocacy.

Rethinking Pediatric Depression: Early Identification and Emerging Treatments

Depression in youth often presents atypically and progresses rapidly without timely intervention. This session reviews updated diagnostic frameworks, neurodevelopmental factors, and treatment innovations including rapid-acting agents and digital therapeutics. Faculty will discuss strategies for early detection in schools and primary care, family engagement, and risk mitigation. Participants will gain tools to identify depressive symptoms earlier, individualize pharmacologic and psychotherapeutic approaches, and improve long-term outcomes.

Speaker

Tuesday, September 15 3:30–4:30 PM
Room Great Hall B
Pediatric Psychiatry
Co-Chair

Julie Carbray

PhD, PMHNP-BC, PMHCNS-BC, FAAN
Clinical Professor of Psychiatry and Nursing
University of Illinois Chicago

Dr. Carbray holds her PhD (93) and Master of Science (88) degrees from Rush University, Chicago and her Bachelor of Science (87) degree from Purdue University in West Lafayette, Indiana. A Clinical Professor of Psychiatry and Nursing at the University of Illinois Chicago, she has been practicing as a Psychiatric Nurse Practitioner over 35 years. As UIC faculty, Dr. Carbray teaches course content in psychopharmacology, mood disorders, and development and therapeutic interventions with children and adolescents for students across various multidisciplinary programs. As the Director of the Pediatric Mood Disorder Clinic, Dr. Carbray leads the clinical program and multidisciplinary training and is a nationally recognized clinical expert in children and adolescents with mood disorders. Dr. Carbray holds a national reputation of excellence in serving families of children with mood disorders, and was recognized with the UIC Preceptor of the year award, the Karen Gousman Excellence in Nursing Award, the American Psychiatric Nurses Association Best Practices in an Outpatient Program for Bipolar Disorder Award, the UIC Inspire Award, the APNA Distinguished Service Award and the Susan McCabe psychopharmacology lectureship from the International Society of Psychiatric Nurses. Dr Carbray has presented her work nationally and internationally and across communities and organizations including the American Girl Company. With a particular focus on helping families to help their children with mood disorders, Dr. Carbray has engaged in programs of research that are investigating the psychopharmacology of mood disorders, neurobiology of mood disorders, and neurobiologically informed treatments and family response to childhood mood disorders.

Faculty

Liv Lewis

Lived Experience Expert
Executive Communications Consultant
Liv Lewis Communications, LLC

Liv Lewis is an Emmy Award-winning producer, Cannes Grand Prix winner, and award-winning communications strategist known for shaping culturally resonant, high-impact brand campaigns. With 20+ years of agency and entrepreneurial experience, she has led integrated marketing and communications for global brands including Calvin Klein, Vera Wang, American Express, McDonald’s, Johnson & Johnson’s Neutrogena, Fannie Mae, Bath & Body Works, Pfizer, Astellas, Banfi Wines, the U.S. Army, and Procter & Gamble brands such as Crest, Tide, Downy, Duracell, Olay, Pantene Gold Series, Mielle, and Old Spice.

Lewis played a pivotal role in P&G’s groundbreaking campaign “The Talk,” which won the Cannes Grand Prix and sparked global conversations on racial bias. She is recognized for strategic foresight, cultural fluency, and the ability to engineer media strategy and partnerships that move audiences from awareness to action.

Drawing on her lived experience, Lewis is also a champion for adolescent mental health—advocating for early identification, reducing stigma, and providing culturally responsive support for youth and families.

Beyond brand work, she founded Livd (pronounced "lived"), a multi-platform community supporting Black and Brown women navigating separation, situationships and divorce, and hosts the Livd Divorce Stories podcast. She also serves as President of the Board of Living After Crisis, a nonprofit that helps individuals rebuild after crisis and trauma. Lewis holds a B.A. in Communications from the University of Maryland, College Park, and an A.A.S. in Advertising and Marketing Communications from the Fashion Institute of Technology. She lives in Teaneck, New Jersey, with her two children.

Faculty

Adelaide Robb

MD
Distinguished Endowed Professor and Chair
Children’s National Hospital, The George Washington University School of Medicine and Health Sciences, Washington, DC

Adelaide Robb, MD, is a professor of Child and Adolescent Psychiatry at George Washington University and Children’s National Health System. Dr. Robb is board-certified in both Adult and Child and Adolescent psychiatry. Dr. Robb did her medical training and general psychiatry residency at the Johns Hopkins University School of Medicine, then completed her fellowship training at the National Institute of Mental Health (NIMH) in psychiatric genetics and at the George Washington University’s Children’s National Medical Center in child and adolescent psychiatry.
Dr. Robb sees children and adolescents with a variety of psychiatric disorders in inpatient and outpatient settings. Her focus is on psychopharmacology, including the study of new medications in children and adolescents with a variety of psychiatric disorders. She served as principal investigator of over 70 pediatric psychopharmacology trials in children and teenagers. Dr. Robb was the site co-PI for the NIMH study Treatment of Early Age Mania (TEAM) and the site PI for the CoLT (Collaborative Lithium Trial) study, which was a NICHD Best Pharmaceuticals for Children Act trial of lithium carbonate for pediatric bipolar disorder.

First-Line Decisions: Lifestyle Modification or Medication? Balancing Pharmacologic and Non-Pharmacologic Care in ADHD

Determining when to initiate pharmacotherapy versus emphasizing behavioral and lifestyle interventions is a key challenge in ADHD treatment. This session will explore how clinicians can make informed first-line treatment decisions, considering symptom severity, patient preference, and co-occurring conditions. Faculty will discuss the role of stimulant and non-stimulant medications, alongside evidence-based behavioral strategies, coaching, and environmental modifications to create personalized, flexible treatment plans that optimize long-term outcomes.

Speaker

Wednesday, September 16 1:30–2:30 PM
Room Great Hall D
First-Line Decisions
Co-Chair

Julie Carbray

PhD, PMHNP-BC, PMHCNS-BC, FAAN
Clinical Professor of Psychiatry and Nursing
University of Illinois Chicago

Dr. Carbray holds her PhD (93) and Master of Science (88) degrees from Rush University, Chicago and her Bachelor of Science (87) degree from Purdue University in West Lafayette, Indiana. A Clinical Professor of Psychiatry and Nursing at the University of Illinois Chicago, she has been practicing as a Psychiatric Nurse Practitioner over 35 years. As UIC faculty, Dr. Carbray teaches course content in psychopharmacology, mood disorders, and development and therapeutic interventions with children and adolescents for students across various multidisciplinary programs. As the Director of the Pediatric Mood Disorder Clinic, Dr. Carbray leads the clinical program and multidisciplinary training and is a nationally recognized clinical expert in children and adolescents with mood disorders. Dr. Carbray holds a national reputation of excellence in serving families of children with mood disorders, and was recognized with the UIC Preceptor of the year award, the Karen Gousman Excellence in Nursing Award, the American Psychiatric Nurses Association Best Practices in an Outpatient Program for Bipolar Disorder Award, the UIC Inspire Award, the APNA Distinguished Service Award and the Susan McCabe psychopharmacology lectureship from the International Society of Psychiatric Nurses. Dr Carbray has presented her work nationally and internationally and across communities and organizations including the American Girl Company. With a particular focus on helping families to help their children with mood disorders, Dr. Carbray has engaged in programs of research that are investigating the psychopharmacology of mood disorders, neurobiology of mood disorders, and neurobiologically informed treatments and family response to childhood mood disorders.

Steering Committee

James Greenblatt

MD
Founder and Medical Director
Psychiatry Redefined

A pioneer in the field of functional and integrative medicine, board-certified child and adult psychiatrist, James M. Greenblatt, MD, has treated patients since 1988. After receiving his medical degree and completing his psychiatry residency at George Washington University, Dr. Greenblatt completed a fellowship in child and adolescent psychiatry at Johns Hopkins Medical School.

Dr. Greenblatt has lectured internationally on the scientific evidence for nutritional interventions in psychiatry and mental illness. He is the author of several books including Finally Focused: The Breakthrough Natural Treatment Plan for ADHD, Finally Hopeful and the upcoming book The Lithium Revolution.

He is the founder of Psychiatry Redefined, an educational platform dedicated to the transformation of psychiatry, which offers online courses, educational webinars, and fellowships for professionals. He is also the founder of Finally Living, a precision functional psychiatry clinic for children and adults. Please visit www.JamesGreenblattMD.com for more information.

MasterClass: Features Out of Focus: Recognition and Treatment of Emotional Dysregulation and Executive Dysfunction in ADHD

ADHD extends beyond inattention and hyperactivity, with executive dysfunction and emotional dysregulation often contributing to long-term impairment. This session explores these underrecognized features, reviews evolving neurobiological insights and emerging pharmacologic options, and provides practical strategies to improve assessment and individualized treatment planning.<br><br>Supported by an educational grant from Otsuka America Pharmaceutical.

Speaker

Wednesday, September 16 2:45–4:15 PM
Room Great Hall A
Co-Chair

Julie Carbray

PhD, PMHNP-BC, PMHCNS-BC, FAAN
Clinical Professor of Psychiatry and Nursing
University of Illinois Chicago

Dr. Carbray holds her PhD (93) and Master of Science (88) degrees from Rush University, Chicago and her Bachelor of Science (87) degree from Purdue University in West Lafayette, Indiana. A Clinical Professor of Psychiatry and Nursing at the University of Illinois Chicago, she has been practicing as a Psychiatric Nurse Practitioner over 35 years. As UIC faculty, Dr. Carbray teaches course content in psychopharmacology, mood disorders, and development and therapeutic interventions with children and adolescents for students across various multidisciplinary programs. As the Director of the Pediatric Mood Disorder Clinic, Dr. Carbray leads the clinical program and multidisciplinary training and is a nationally recognized clinical expert in children and adolescents with mood disorders. Dr. Carbray holds a national reputation of excellence in serving families of children with mood disorders, and was recognized with the UIC Preceptor of the year award, the Karen Gousman Excellence in Nursing Award, the American Psychiatric Nurses Association Best Practices in an Outpatient Program for Bipolar Disorder Award, the UIC Inspire Award, the APNA Distinguished Service Award and the Susan McCabe psychopharmacology lectureship from the International Society of Psychiatric Nurses. Dr Carbray has presented her work nationally and internationally and across communities and organizations including the American Girl Company. With a particular focus on helping families to help their children with mood disorders, Dr. Carbray has engaged in programs of research that are investigating the psychopharmacology of mood disorders, neurobiology of mood disorders, and neurobiologically informed treatments and family response to childhood mood disorders.

Co-Chair

Gregory Mattingly

MD
Associate Clinical Professor, Department of Psychiatry
Washington University School of Medicine, Midwest Research Group, St. Louis, MO, United States

Dr. Mattingly is a physician and principal investigator in clinical trials for Midwest Research Group. He is also a founding partner of St. Charles Psychiatric Associates where he treats children, adolescents and adults. A St Louis native, he earned his medical degree and received a Fulbright scholarship while attending Washington University. Dr. Mattingly is board certified in adult and adolescent psychiatry and is a Diplomat of the National Board of Medical Examiners. He is an Associate Clinical Professor at Washington University where he teaches psychopharmacology courses for the 3rd year medical students. Dr. Mattingly has been a principal investigator in over 400 clinical trials focusing on ADHD, anxiety disorders, major depression, bipolar disorder and schizophrenia. Having served on numerous national and international advisory panels, Dr. Mattingly has received awards and distinctions for clinical leadership and neuroscience research. Dr Mattingly is the President for APSARD-The American Professional Society of ADHD and Related Disorders and is on the Scientific Advisory Board for the Workd Federation of ADHD. Having served on the board of Headway House, a community support program and as a certifed evaluator for both the NFL and MLB, Dr Mattingly is firm believer in holistic mental health, education and advocacy.

Psych Congress 2026: Final Thoughts and Panel Discussion

Speaker

Saturday, September 19 4:00–4:15 PM
Room Great Hall A
Co-Chair

Julie Carbray

PhD, PMHNP-BC, PMHCNS-BC, FAAN
Clinical Professor of Psychiatry and Nursing
University of Illinois Chicago

Dr. Carbray holds her PhD (93) and Master of Science (88) degrees from Rush University, Chicago and her Bachelor of Science (87) degree from Purdue University in West Lafayette, Indiana. A Clinical Professor of Psychiatry and Nursing at the University of Illinois Chicago, she has been practicing as a Psychiatric Nurse Practitioner over 35 years. As UIC faculty, Dr. Carbray teaches course content in psychopharmacology, mood disorders, and development and therapeutic interventions with children and adolescents for students across various multidisciplinary programs. As the Director of the Pediatric Mood Disorder Clinic, Dr. Carbray leads the clinical program and multidisciplinary training and is a nationally recognized clinical expert in children and adolescents with mood disorders. Dr. Carbray holds a national reputation of excellence in serving families of children with mood disorders, and was recognized with the UIC Preceptor of the year award, the Karen Gousman Excellence in Nursing Award, the American Psychiatric Nurses Association Best Practices in an Outpatient Program for Bipolar Disorder Award, the UIC Inspire Award, the APNA Distinguished Service Award and the Susan McCabe psychopharmacology lectureship from the International Society of Psychiatric Nurses. Dr Carbray has presented her work nationally and internationally and across communities and organizations including the American Girl Company. With a particular focus on helping families to help their children with mood disorders, Dr. Carbray has engaged in programs of research that are investigating the psychopharmacology of mood disorders, neurobiology of mood disorders, and neurobiologically informed treatments and family response to childhood mood disorders.

Co-Chair

Rakesh Jain

MD, MPH
Clinical Professor
Texas Tech - Permian Basin

Rakesh Jain, MD, MPH, attended medical school at the University of Calcutta in India. He then attended graduate school at the University of Texas School of Public Health in Houston, where he was awarded a “National Institute/Center for Disease Control Competitive Traineeship”. His research thesis focused on impact of substance abuse. He graduated from the School of Public Health in 1987 with a Masters of Public Health (MPH) degree.

Dr. Jain served a three-year residency in Psychiatry at the Department of Psychiatry and Behavioral Sciences at the University of Texas Medical School at Houston. He followed that by obtaining further specialty training, by undergoing a two-year fellowship in Child and Adolescent Psychiatry. In addition, Dr. Jain completed a postdoctoral fellowship in Research Psychiatry at the University of Texas Mental Sciences Institute, in Houston. He was awarded the “National Research Service Award” for the support of this postdoctoral fellowship.

Co-Chair

Gregory Mattingly

MD
Associate Clinical Professor, Department of Psychiatry
Washington University School of Medicine, Midwest Research Group, St. Louis, MO, United States

Dr. Mattingly is a physician and principal investigator in clinical trials for Midwest Research Group. He is also a founding partner of St. Charles Psychiatric Associates where he treats children, adolescents and adults. A St Louis native, he earned his medical degree and received a Fulbright scholarship while attending Washington University. Dr. Mattingly is board certified in adult and adolescent psychiatry and is a Diplomat of the National Board of Medical Examiners. He is an Associate Clinical Professor at Washington University where he teaches psychopharmacology courses for the 3rd year medical students. Dr. Mattingly has been a principal investigator in over 400 clinical trials focusing on ADHD, anxiety disorders, major depression, bipolar disorder and schizophrenia. Having served on numerous national and international advisory panels, Dr. Mattingly has received awards and distinctions for clinical leadership and neuroscience research. Dr Mattingly is the President for APSARD-The American Professional Society of ADHD and Related Disorders and is on the Scientific Advisory Board for the Workd Federation of ADHD. Having served on the board of Headway House, a community support program and as a certifed evaluator for both the NFL and MLB, Dr Mattingly is firm believer in holistic mental health, education and advocacy.

Back to top